SCHEMBL29650200

SCHEMBL29650200

O=S(=O)(CC1CC1)c1cccc(O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.43
HSD17B1 P14061 5/20 0.42
HSD17B2 P37059 5/20 0.42
CA2 P00918 1/20 0.41
MMP2 P08253 2/20 0.40
PKM P14618 1/20 0.40
OPRM1 P35372 3/20 0.40
OPRK1 P41145 3/20 0.40
OPRD1 P41143 2/20 0.40
KIF18A Q8NI77 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HTR7 P34969 3/20 0.39
CYP2D6 P10635 2/20 0.39
HTR1B P28222 2/20 0.39
DRD3 P35462 2/20 0.39
HTR5A P47898 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19692897 1.00 HTR6 (0.43) HTR6HSD17B1HSD17B2CA2MMP2
SCHEMBL19707164 0.93 HTR6 (0.44) HTR6HSD17B1HSD17B2CA2MMP2
SCHEMBL1710586 0.92 OPRM1 (0.43) HTR6HSD17B1HSD17B2OPRM1OPRK1
SCHEMBL19277085 0.80 MMP2 (0.40) HTR6MMP2KIF18AALDH1A1GAA
SCHEMBL2535633 0.79 CRBN (0.41) KIF18AALDH1A1GAAMAPTSMN1; SMN2
SCHEMBL522247 0.79 MBTD1 (0.44) HTR6MMP2ALDH1A1GAAMAPT
SCHEMBL28229855 0.79 ALDH1A1 (0.56) HTR6MMP2ALDH1A1GAAMAPT
SCHEMBL5416488 0.79 AKR1C3 (0.51) CA2ALDH1A1MAPT
SCHEMBL16799946 0.76 AKR1B1 (0.42) KIF18AALDH1A1GAAMAPTCYP1A2
SCHEMBL2642996 0.76 PSIP1 (0.56) HSD17B1HSD17B2CA2MMP2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-B Modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2022-05-27 CN disclosed